Reporter
Pal named to cancer research national leadership posts
Dec. 28, 2020—Tuya Pal, MD, Ingram Professor of Cancer Research and associate director for Cancer Health Disparities at Vanderbilt-Ingram Cancer Center, has been named to two cancer research leadership posts.
UT Southwestern’s Rosen up next in Discovery Lecture Series
Dec. 22, 2020—Michael Rosen, PhD, professor and chair of Biophysics at the University of Texas Southwestern Medical Center, will discuss mysterious cellular compartments known as “biomolecular condensates” during the next web-based Discovery Lecture.
Pancreatlas provides access to complex images of the human pancreas
Dec. 22, 2020—Images of cells and tissues are a critical part of biomedical research as they show which molecules or proteins are present and where these molecules are located in the tissue. Using increasingly sophisticated microscopes and imaging approaches, scientists can now look at more than 40 different molecules at once, an approach known as multi-plex imaging, where in the past they could only look at three or four molecules at a time.
Arthritis drug may treat immunotherapy-related heart complication
Dec. 22, 2020—by Tom Wilemon A drug typically prescribed for rheumatoid arthritis may also be effective in treating a rare but potentially deadly heart complication some cancer patients experience after taking immunotherapies, according to a study published in Cancer Discovery and co-led by investigators at Vanderbilt University Medical Center. The researchers demonstrated that the drug abatacept reduced...
HERO-TOGETHER study seeks health care workers who receive COVID-19 vaccine
Dec. 21, 2020—Health care workers, who have been disproportionately affected by the COVID-19 pandemic, will be the first tier of Vanderbilt University Medical Center employees to receive vaccine to prevent SARS-CoV-2 infection.
Rounds: A Holiday Gift
Dec. 21, 2020—Against the noisy background of masking debates, surges, flattening curves, warp speed initiatives, conflicting messages and misinformation, political controversies, not to mention a revolutionary mRNA technology, millions of people are deciding whether to take the COVID-19 vaccine.
Tennessee’s uninsured children have doubled since 2019 and 2 in 5 live with food insecurity, poll finds
Dec. 21, 2020—In fall 2020, 9% of Tennessee children were uninsured, more than twice the level at the same time in 2019, according to a new poll conducted by the Vanderbilt Center for Child Health Policy. Just 4% of children were uninsured in fall 2019, the poll found.
Vanderbilt University Medical Center begins giving COVID-19 vaccines to front-line caregivers
Dec. 17, 2020—Vanderbilt University Medical Center began vaccinating its front-line caregivers for COVID-19 on Thursday, Dec. 17.
Challenges, achievements share spotlight in 2020
Dec. 17, 2020—The year 2020 will forever be defined by the global COVID-19 pandemic, and Vanderbilt University Medical Center’s response to it has been nothing short of stunning. The entire enterprise — clinical, research and education — began preparing for the pandemic’s impact even before the first cases appeared in Tennessee in March, and that dedicated commitment and unceasing effort did not waver in the long months that followed. But while COVID-19 dominated the news during 2020, there were still many other noteworthy achievements that made headlines during the year.
Year in Review 2020: Medical Center shines in multiple national rankings
Dec. 17, 2020—During the past year, Vanderbilt University Medical Center placed highly in several national rankings and was honored with numerous awards.
Year in Review 2020: Leadership appointments bolster VUMC’s missions
Dec. 17, 2020—New leadership appointments during the past year helped strengthen Vanderbilt University Medical Center's core missions.
Clinic uses new weapon to treat high-risk COVID patients
Dec. 17, 2020—Vanderbilt University Medical Center has a new weapon in the fight against COVID-19 — an investigational antibody treatment approved last month for emergency use in COVID-19 outpatients at high risk of developing severe disease or requiring hospital care.
